(VIANEWS) - Fulton Financial Corporation (FULT), Western Alliance Bancorporation (WAL), United Therapeutics Corporation (UTHR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Fulton Financial Corporation (FULT)
40.2% sales growth and 10.33% return on equity
Fulton Financial Corporation is a financial holding firm that offers commercial and consumer banking products. The company accepts checking and savings deposits, certificates of deposit and individual retirement accounts. Secured consumer loans include home equity loans and personal lines of credit; automobile loans, checking account protection; construction and residential mortgage loans; commercial lending products that consist of commercial, industrial and construction loans as well as equipment leasing financing loans. It also offers letters of credit and cash management services. Wealth management services include investment management, trust brokerage, insurance and investment advisory. The company also owns trust preferred securities and passive investments. It also sells life insurance products. The company offers its services via traditional banking and telephone banking. There were branches throughout Pennsylvania, Maryland Delaware, New Jersey and Virginia. Fulton Financial Corporation was founded in 1882. It is located in Lancaster, Pennsylvania.
Earnings Per Share
As for profitability, Fulton Financial Corporation has a trailing twelve months EPS of $1.56.
PE Ratio
Fulton Financial Corporation has a trailing twelve months price to earnings ratio of 10.58. Meaning, the purchaser of the share is investing $10.58 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.33%.Sales Growth
Fulton Financial Corporation's sales growth is 33.9% for the present quarter and 40.2% for the next.
Annual Top and Bottom Value
Fulton Financial Corporation stock was valued at $16.51 as of 10:22 EST. This is way lower than the 52-week high at $19.17, and much higher than the 52-week low at $13.72.
2. Western Alliance Bancorporation (WAL)
34.5% sales growth and 21.19% return on equity
Western Alliance Bancorporation operates as the bank holding company for Western Alliance Bank that provides various banking products and related services primarily in Arizona, California, and Nevada. It operates in Commercial, Consumer Related, and Corporate & Other segments. The company offers deposit products, including checking, savings, and money market accounts, as well as fixed-rate and fixed maturity certificates of deposit accounts; and treasury management and residential mortgage products and services. It also offers commercial and industrial loan products, such as working capital lines of credit, loans to technology companies, inventory and accounts receivable lines, mortgage warehouse lines, equipment loans and leases, and other commercial loans; commercial real estate loans, which are secured by multi-family residential properties, professional offices, industrial facilities, retail centers, hotels, and other commercial properties; construction and land development loans for single family and multi-family residential projects, industrial/warehouse properties, office buildings, retail centers, medical office facilities, and residential lot developments; and consumer loans. In addition, the company provides other financial services, such as internet banking, wire transfers, electronic bill payment and presentment, lock box services, courier, and cash management services. Further, it holds certain investment securities, municipal and non-profit loans, and leases; invests primarily in low-income housing tax credits and small business investment corporations; and holds certain real estate loans and related securities. The company operates 36 branch locations, as well as loan production offices. Western Alliance Bancorporation was founded in 1994 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Western Alliance Bancorporation has a trailing twelve months EPS of $9.31.
PE Ratio
Western Alliance Bancorporation has a trailing twelve months price to earnings ratio of 6.53. Meaning, the purchaser of the share is investing $6.53 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.19%.Annual Top and Bottom Value
Western Alliance Bancorporation stock was valued at $60.76 as of 10:22 EST. This is way lower than its 52 week high of $124.93 but higher than its 52-week low, $54.86.
Moving Average
Western Alliance Bancorporation's worth is below its 50-day moving average of $66.57 and way under its 200-day moving average of $75.03.Sales Growth
Western Alliance Bancorporation's sales growth is 29.1% for the current quarter and 34.5% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 16, 2022, the estimated forward annual dividend rate is 1.44 and the estimated forward annual dividend yield is 2.37%.
3. United Therapeutics Corporation (UTHR)
20.8% sales growth and 15.85% return on equity
United Therapeutics Corporation is a biotechnology firm that develops and markets products for patients suffering from life-threatening and chronic diseases. Remodulin is a subcutaneous or intravenous formulation of the prostacyclin analog treprostinil. Tyvaso, which treats PAH patients, contains a tablet dose form of treprostinil. Orenitram also has a tablet formulation. Unituxin, a monoclonal anti-inflammatory antibody, can be used to treat high-risk neuroblastoma. Adcirca is an oral PDE-5 inhibitor that improves the PAH patient's exercise. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. To commercialize and develop the implantable Remodulin system, it has entered into licensing and cooperation agreements with Medtronic, Inc. and Caremark, L.L.C. It will provide refills for implanted pumps at its centers. DEKA Research & Development Corp. will develop a semi-disposable system to deliver Remodulin subcutaneously; MannKind Corporation will license treprostinil Inhalation Powder and Dreamboat devices. Arena Pharmaceuticals, Inc., is developing ralinepag to treat PAH. Silver Spring, Maryland is the headquarters of this company.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $11.54.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 24.17. Meaning, the purchaser of the share is investing $24.17 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.85%.Moving Average
United Therapeutics Corporation is worth more than its moving average for 50 days of $251.52 or its moving average for 200 days of $219.37.Annual Top and Bottom Value
At 10:22 EST United Therapeutics Corporation stock was valued at $278.96. This is below its 52-week peak of $283.09, and well above its 52 week low of $158.38.
4. Peapack-Gladstone Financial Corporation (PGC)
17.7% sales growth and 12.95% return on equity
Peapack–Gladstone Financial Corporation is the bank holding firm for Peapack–Gladstone Bank, which provides wealth management and private banking services in the United States. Peapack Private and Banking are the two main segments of the company. The company offers individual retirement accounts as well as checking and savings accounts. It also offers working capital lines, term loans to fix fixed assets, commercial mortgages and multi-family mortgages and other asset-based financing options. Residential mortgages and home equity loans are available as well. It also offers equipment and corporate finance (C&I), multifamily residential and commercial lending, treasury management, C&I advisory, escrow management, deposit generation, asset and investment management, personal trust services including executors, trustees, administrators, custodians, guardians, as well as other services in financial planning, tax preparation and advice. The company also offers telephone banking and merchant credit cards, as well as customer support and sales services. Private banking clients are businesses and non-profits as well as consumers. Wealth management clients consist of individuals, families and foundations. Endowments, trusts and trusts can also be included. It has private banks in Teaneck, Princeton, Morristown and Teaneck in New Jersey. Wealth management branches are also available in Somerset, Morris and Hunterdon counties. There is also an automated teller machine at twenty locations. Peapack Gladstone Financial Corporation was established in New Jersey in 1921. It is located in Bedminster.
Earnings per Share
Peapack Gladstone Financial Corporation's trailing 12 months profit per share was $3.66
PE Ratio
Peapack Gladstone Financial Corporation's trailing 12-month price-earnings ratio is 9.92. The purchaser of the shares is therefore investing $9.92 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 12.95%.Volume
Today's last reported volume for Peapack-Gladstone Financial Corporation is 180603 which is 163.63% above its average volume of 68506.
Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is 35.4% and 52.1%, respectively.5. The Ensign Group (ENSG)
13.4% sales growth and 19.72% return on equity
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $3.75.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 25.5. Meaning, the purchaser of the share is investing $25.5 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.72%.Annual Top and Bottom Value
At 10:22 EST The stock of Ensign Group is worth $95.64, which is below its 52 week high of $96.51 but much higher than its low 52-week of $70.29.
Sales Growth
The Ensign Group's sales growth is 15.6% for the current quarter and 13.4% for the next.
Dividend Yield
Morningstar, Inc. claims that the next dividend payment will be on Sep 28th 2022. The forward dividend rate and yield are 0.22 percent and 0.24% respectively.
6. Global Self Storage (SELF)
11.2% sales growth and 6.31% return on equity
Global Self Storage, a REIT self-managed and managed by the investor, owns, operates and manages self-storage properties. Its self-storage facilities are affordable and easy to access for commercial and residential customers. The company has 13 self-storage facilities in Connecticut, Illinois and Indiana. It also manages them through its subsidiaries.
Earnings per Share
Global Self Storage's trailing 12 month EPS is $0.29.
PE Ratio
Global Self Storage's trailing 12 months earnings to price ratio is 17.17. The purchaser of the shares is investing $17.17 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 6.31%.7. CubeSmart (CUBE)
8.8% sales growth and 9.86% return on equity
CubeSmart is a self-administered and self-managed real estate investment trust. The Company's self-storage properties are designed to offer affordable, easily accessible and secure storage space for residential and commercial customers. According to the 2020 Self-Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the United States.
Earnings Per Share
As for profitability, CubeSmart has a trailing twelve months EPS of $1.14.
PE Ratio
CubeSmart has a trailing twelve months price to earnings ratio of 36.92. Meaning, the purchaser of the share is investing $36.92 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.86%.Sales Growth
CubeSmart's sales growth is 16.7% for the current quarter and 8.8% for the next.